RU2005105688A - Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты - Google Patents
Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты Download PDFInfo
- Publication number
- RU2005105688A RU2005105688A RU2005105688/04A RU2005105688A RU2005105688A RU 2005105688 A RU2005105688 A RU 2005105688A RU 2005105688/04 A RU2005105688/04 A RU 2005105688/04A RU 2005105688 A RU2005105688 A RU 2005105688A RU 2005105688 A RU2005105688 A RU 2005105688A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- crystalline form
- dodecachydrocyclopent
- phenanthrenyl
- Prior art date
Links
- QERYCTSHXKAMIS-UHFFFAOYSA-N thiophene-2-carboxylic acid Chemical compound OC(=O)C1=CC=CS1 QERYCTSHXKAMIS-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 9
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 3
- 208000011623 Obstructive Lung disease Diseases 0.000 claims 1
- 238000002441 X-ray diffraction Methods 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 238000000354 decomposition reaction Methods 0.000 claims 1
- 238000000113 differential scanning calorimetry Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000010438 heat treatment Methods 0.000 claims 1
- 208000027866 inflammatory disease Diseases 0.000 claims 1
- 230000002757 inflammatory effect Effects 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 238000002844 melting Methods 0.000 claims 1
- 230000008018 melting Effects 0.000 claims 1
- 238000000034 method Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 230000002269 spontaneous effect Effects 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J33/00—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton
- C07J33/002—Normal steroids having a sulfur-containing hetero ring spiro-condensed or not condensed with the cyclopenta(a)hydrophenanthrene skeleton not condensed
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Claims (7)
1. Соединение формулы I
в кристаллической форме В, температура плавления которой по данным дифференциальной сканирующей калориметрии составляет приблизительно 270°С при самопроизвольном разложении при скорости нагревания 20°С/мин, и которая характеризуется следующей рентгеноструктурной дифракционной картиной с характерными дифракционными полосами (2θ в угловых градусах ±0,2°): 7,2°, 9,3°, 12,0°, 12,8°, 13,1°, 14,5°, 17,4°, 20,4°, 23,2° и 25,8°.
2. Фармацевтическая композиция, включающая активный ингредиент, эффективное количество соединения формулы I в кристаллической форме В по п.1, необязательно в смеси с фармацевтически приемлемым носителем.
3. Соединение по п.2, которое находится в форме для ингаляции.
4. Применение соединения по п.1 в кристаллической форме В для получения лекарственного средства, предназначенного для лечения воспалительного или обструктивного заболевания легких.
5. Способ получения соединения формулы I в кристаллической форме В по п.1, включающий кристаллизацию соединения формулы I по п.1 из раствора указанного соединения в этаноле, метаноле или хлористом метилене.
6. Кристаллическая форма соединения формулы I, как она описана в описании настоящего изобретения со ссылкой на любой пример.
7. Кристаллическая форма соединения формулы I, как она описана в описании настоящего изобретения со ссылкой на любую фигуру.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0217504.0A GB0217504D0 (en) | 2002-07-29 | 2002-07-29 | Organic compounds |
| GB0217504.0 | 2002-07-29 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007143025/04A Division RU2348646C1 (ru) | 2002-07-29 | 2003-07-28 | Полиморфизм додекагидроциклопента[а]фенантренилового эфира тиофенкарбоновой кислоты |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2005105688A true RU2005105688A (ru) | 2005-10-10 |
| RU2330043C2 RU2330043C2 (ru) | 2008-07-27 |
Family
ID=9941275
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007143025/04A RU2348646C1 (ru) | 2002-07-29 | 2003-07-28 | Полиморфизм додекагидроциклопента[а]фенантренилового эфира тиофенкарбоновой кислоты |
| RU2005105688/04A RU2330043C2 (ru) | 2002-07-29 | 2003-07-28 | Полиморфизм додекагидроциклопента [а] фенантренилового эфира тиофенкарбоновой кислоты |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2007143025/04A RU2348646C1 (ru) | 2002-07-29 | 2003-07-28 | Полиморфизм додекагидроциклопента[а]фенантренилового эфира тиофенкарбоновой кислоты |
Country Status (30)
| Country | Link |
|---|---|
| US (1) | US7683048B2 (ru) |
| EP (2) | EP1676854A1 (ru) |
| JP (1) | JP2006501207A (ru) |
| KR (1) | KR100688371B1 (ru) |
| CN (1) | CN1305892C (ru) |
| AR (1) | AR040692A1 (ru) |
| AT (1) | ATE349459T1 (ru) |
| AU (1) | AU2003251651B2 (ru) |
| BR (1) | BR0313044A (ru) |
| CA (1) | CA2493330C (ru) |
| CY (1) | CY1106406T1 (ru) |
| DE (1) | DE60310747T2 (ru) |
| DK (1) | DK1554303T3 (ru) |
| EC (1) | ECSP055579A (ru) |
| ES (1) | ES2279970T3 (ru) |
| GB (1) | GB0217504D0 (ru) |
| HK (1) | HK1080484B (ru) |
| IL (2) | IL166287A0 (ru) |
| MX (1) | MXPA05001173A (ru) |
| MY (1) | MY136407A (ru) |
| NO (1) | NO20050806L (ru) |
| NZ (2) | NZ537868A (ru) |
| PE (1) | PE20040722A1 (ru) |
| PL (1) | PL209409B1 (ru) |
| PT (1) | PT1554303E (ru) |
| RU (2) | RU2348646C1 (ru) |
| SI (1) | SI1554303T1 (ru) |
| TW (1) | TWI309164B (ru) |
| WO (1) | WO2004013156A1 (ru) |
| ZA (1) | ZA200500370B (ru) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6858596B2 (en) | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| KR100889426B1 (ko) | 2000-08-05 | 2009-03-23 | 글락소 그룹 리미티드 | 항염증제로서의 6.알파.,9.알파.-디플루오로-17.알파.-'(2-푸라닐카르복실)옥시-11.베타.-히드록시-16.알파.-메틸-3-옥소-안드로스트-1,4-디엔-17-카르보티오산 ｓ-플루오로메틸 에스테르 |
| US6777399B2 (en) | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| GB0019172D0 (en) | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| AU2002253342B2 (en) | 2001-04-30 | 2007-01-04 | Glaxo Group Limited | Novel anti-inflammatory androstane derivatives |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| GB0523656D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0523654D0 (en) * | 2005-11-21 | 2005-12-28 | Novartis Ag | Organic compounds |
| GB0603783D0 (en) * | 2006-02-24 | 2006-04-05 | Novartis Ag | Organic compounds |
| EP2280708A1 (en) * | 2008-03-14 | 2011-02-09 | Otsuka Pharmaceutical Co., Ltd. | Mmp-2 and/or mmp-9 inhibitor |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU550939A1 (ru) * | 1975-05-19 | 1994-07-15 | Институт химии древесины АН ЛатвССР | 1,2,3,4,4а,4в,5,6,10,10а -декагидро -6- хлорацетоксиметил -1,4а-диметил -7- (1-метилэтил) -1- фенантренкарбоновая кислота или ее соли |
| JPH08291073A (ja) * | 1995-04-22 | 1996-11-05 | Kissei Pharmaceut Co Ltd | 医薬品組成物及びその製造方法 |
| GB0015876D0 (en) * | 2000-06-28 | 2000-08-23 | Novartis Ag | Organic compounds |
-
2002
- 2002-07-29 GB GBGB0217504.0A patent/GB0217504D0/en not_active Ceased
-
2003
- 2003-07-25 AR AR20030102680A patent/AR040692A1/es unknown
- 2003-07-25 PE PE2003000741A patent/PE20040722A1/es not_active Application Discontinuation
- 2003-07-28 PT PT03766325T patent/PT1554303E/pt unknown
- 2003-07-28 AU AU2003251651A patent/AU2003251651B2/en not_active Ceased
- 2003-07-28 BR BR0313044-4A patent/BR0313044A/pt not_active IP Right Cessation
- 2003-07-28 EP EP06005390A patent/EP1676854A1/en not_active Withdrawn
- 2003-07-28 RU RU2007143025/04A patent/RU2348646C1/ru not_active IP Right Cessation
- 2003-07-28 AT AT03766325T patent/ATE349459T1/de active
- 2003-07-28 DE DE60310747T patent/DE60310747T2/de not_active Expired - Lifetime
- 2003-07-28 KR KR1020057001581A patent/KR100688371B1/ko not_active Expired - Fee Related
- 2003-07-28 EP EP03766325A patent/EP1554303B1/en not_active Expired - Lifetime
- 2003-07-28 CN CNB038180596A patent/CN1305892C/zh not_active Expired - Fee Related
- 2003-07-28 JP JP2004525343A patent/JP2006501207A/ja active Pending
- 2003-07-28 SI SI200330721T patent/SI1554303T1/sl unknown
- 2003-07-28 TW TW092120513A patent/TWI309164B/zh not_active IP Right Cessation
- 2003-07-28 NZ NZ537868A patent/NZ537868A/en unknown
- 2003-07-28 RU RU2005105688/04A patent/RU2330043C2/ru not_active IP Right Cessation
- 2003-07-28 MY MYPI20032832A patent/MY136407A/en unknown
- 2003-07-28 NZ NZ549713A patent/NZ549713A/en unknown
- 2003-07-28 DK DK03766325T patent/DK1554303T3/da active
- 2003-07-28 HK HK06100247.5A patent/HK1080484B/en not_active IP Right Cessation
- 2003-07-28 WO PCT/EP2003/008314 patent/WO2004013156A1/en not_active Ceased
- 2003-07-28 US US10/522,358 patent/US7683048B2/en not_active Expired - Fee Related
- 2003-07-28 ES ES03766325T patent/ES2279970T3/es not_active Expired - Lifetime
- 2003-07-28 MX MXPA05001173A patent/MXPA05001173A/es active IP Right Grant
- 2003-07-28 PL PL373140A patent/PL209409B1/pl not_active IP Right Cessation
- 2003-07-28 CA CA2493330A patent/CA2493330C/en not_active Expired - Fee Related
-
2005
- 2005-01-13 IL IL16628705A patent/IL166287A0/xx unknown
- 2005-01-14 ZA ZA200500370A patent/ZA200500370B/en unknown
- 2005-01-26 EC EC2005005579A patent/ECSP055579A/es unknown
- 2005-02-15 NO NO20050806A patent/NO20050806L/no unknown
-
2007
- 2007-03-22 CY CY20071100400T patent/CY1106406T1/el unknown
- 2007-07-26 IL IL184848A patent/IL184848A0/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FI62821C (fi) | Foerfarande foer framstaellning av nya terapeutiskt anvaendbara hydroxamsyror | |
| JP4996786B2 (ja) | 結晶質の化合物ビス［（ｅ）−７−［４−（４−フルオロフェニル）−６−イソプロピル−２−［メチル（メチルスルホニル）アミノ］ピリミジン−５−イル］（３ｒ，５ｓ）−３，５−ジヒドロキシ−６−ヘプテン酸］カルシウム塩 | |
| HU229700B1 (en) | Calcium salt of (3s) tetrahydro-3-furanyl(1s,2r)-3-[[(4-aminophenyl)sulfonyl]-(isobutyl)amino]-1-benzyl-2-(phosphonooxy) propylcarbamate, pharmaceutical composition containing the compound and process for preparation the same | |
| JP2010132669A (ja) | ストロンチウムラネレートのアルファー（α）−結晶形、その製造方法、及びそれを含む医薬組成物 | |
| JP2009084270A5 (ru) | ||
| RU2001111875A (ru) | Омепразол формы А, способ его получения, фармацевтиченский препарат на его основе и способ лечения желудочно-кишечных расстройств | |
| JP2004513940A5 (ru) | ||
| JP2004537597A5 (ru) | ||
| RU2005105688A (ru) | Полиморфизм додекагидроциклопента (а) фенантренилового эфира тиофенкарбоновой кислоты | |
| NO141756B (no) | Analogifremgangsmaate for fremstilling av antiparasittisk aktive salicylanilidderivater | |
| HU179170B (en) | Process for producing phenethanolamine derivatives | |
| JP2007505879A (ja) | 既知の抗高脂血症剤の多形体 | |
| JP2004525178A5 (ru) | ||
| JP2012512145A (ja) | フリバンセリンの結晶性の塩形態 | |
| KR20200081359A (ko) | 2-(5-(4-(2-모르폴리노에톡시)페닐)피리딘-2-일)-n-벤질아세트아미드의 고체 형태 | |
| JP6275644B2 (ja) | Ｎ−［２−（｛２−［（２Ｓ）−２−シアノピロリジン−１−イル］−２−オキソエチル｝アミノ）−２−メチルプロピル］−２−メチルピラゾロ［１，５−ａ］ピリミジン−６−カルボキサミドの結晶 | |
| RU2451016C2 (ru) | Тозилатная соль транс-n-изобутил-3-фтор-3-[3-фтор-4-(пирролидин-1-илметил)фенил]циклобутанкарбоксамида | |
| US12384784B2 (en) | Polymorphs of Acalabrutinib, a Bruton's tyrosine kinase inhibitor | |
| CN1214029C (zh) | 4－氨基－6,7－二甲氧基－2－(5－甲磺酰氨基－1,2,3,4－四氢异喹啉－2－基)－5－(2－吡啶基)喹唑啉甲磺酸盐及多晶形物 | |
| JPS62190184A (ja) | ８α−アクリルアミノエルゴリン、その製造方法および該化合物を含有する医薬組成物 | |
| PL128998B1 (en) | Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives | |
| JP3830816B2 (ja) | アザビシクロ（２．２．２）オクタン−３−アミンクエン酸塩の結晶多形及びそれらの医薬組成物 | |
| JPS606946B2 (ja) | Ｎ−（３，３−ジフエニルプロピル）−ｎ’−アラルキル置換ピペラジンおよびその塩の製法 | |
| JP2008520611A5 (ru) | ||
| US20160193165A1 (en) | Novel polymorphs and salts |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140729 |